Cheryl Cohen, Director at ImmunityBio, Inc. (IBRX), sold 81,056 shares at $10.50 ($851K) on 2026-10-02, disclosed to the SEC on 2026-10-06.
Scheduled sale ($851k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IBRX | SELL | 2021-08-19 | $900K | — | Filing → |
| NK | SELL | 2020-08-13 | $299K | — | Filing → |
| VTL | SELL | 2018-09-14 | $2K | — | Filing → |